Skip to content

Impact of Bariatric Surgery on Epicardial Adipose Tissue and on Myocardial Function

Impact of Bariatric Surgery on Epicardial Adipose Tissue and on Myocardial Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01284816
Enrollment
44
Registered
2011-01-27
Start date
2010-09-30
Completion date
Unknown
Last updated
2015-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severely Obese Patients

Keywords

severely obese patients

Brief summary

Growing evidence suggests that bariatric surgery is a relevant treatment for severely obese patients, especially those with metabolic complications, as it significantly reduces weight, hypertension and ameliorates glycemic control. Its action on adipose tissue distribution and in particular on epicardial adipose tissue EAT remains unknown. Whether metabolic improvement is associated with EAT reduction is also unknown. The researchers thus investigated the effect of bariatric surgery on EAT in severely obese patients. The primary endpoint of this study was the change in EAT amount 6 months after bariatric surgery.

Detailed description

The best of our knowledge, no study has really addressed whether this EAT was modulated by diet or therapeutics like bariatric surgery. The researchers were particularly interested in studying the impact of bariatric surgery and of weight loss on the amount of EAT and whether reduction in EAT could have a positive impact on myocardial function.

Interventions

PROCEDUREbariatric surgery

The bariatric surgery is a relevant treatment for severely obese patients those with metabolic complications, as it significantly reduces weight, hypertension and ameliorates glycemic control.

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Intervention model
CROSSOVER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* men or women who have more than 18 years * patients have been informed and have consented * severely obese patients with surgery indication

Exclusion criteria

* contraindications at surgery, at MNR imagery * History of infarct, of congenital cardiomyopathy * Treatment modifying the distribution of the fat * Pregnant or breast-feeding women * patients less than 18 years * Patient without consentment

Design outcomes

Primary

MeasureTime frameDescription
The change in EAT amount 6 months after bariatric surgery.36 monthsWe thus investigated the effect of bariatric surgery on EAT in severely obese patients.

Secondary

MeasureTime frameDescription
Evaluation of 3 parameters36 months1. to evaluate the variation in myocardial, hepatic , pancreatic and triglyceride content 2. to evaluate the variation in left ventricular function or myocardial function 3. and to describe the relationships between changes in visceral abdominal fat, subcutaneous fat and epicardial fat

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026